Oncology

The oncology treatment landscape continues to evolve at speed, creating knowledge gaps with each new fast-tracked approval and change in standard of care.  

At Ipsos, we speak oncology – thanks to dedicated custom oncology teams worldwide, oncology access and advisory expertise, and long-standing Global Oncology Monitors offering market-leading oncology real-world evidence, validated prevalence figures, and other insights.

Our additional focus on the use of molecular diagnostics provides further granularity into changing oncology treatment paradigms and individualised approaches.

Whatever your business question, Ipsos' Oncology CoE ensures that the best expertise, insights and approaches from across the Ipsos globe are used to answer it.

Learn more  
Ipsos Global Oncology Monitor

Recent thought leadership  
PoV: Would You Want to Know? The Paradox of Early Cancer Detection
PoV: Does Everything Really Cause Cancer?
Report: Mid-year Oncology Review 2025: History Informs the Future
PoV: Why are ADCs so Hot Right Now?
Webinar: Evaluating Time & Treatment While Living with Metastatic Breast Cancer
Paper & Podcast: Mastering Complexity: The Path to a Cancer-free Reality
Online Abstract (ASCO 2025): Observational Study on GLP-1 Use in Breast Cancer Patients
Clinical Poster (SITC 2024): PD-L1 Expression Thresholds Guide Cytotoxic Prescribing in NSCLC

Tell us your oncology business questions.